Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers

Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers

Since the end of 2019, global healthcare systems have been dealing with the COVID-19 pandemic. In oncology, the biggest questions concern interaction of COVID-19 with pre-existing cancer disease and with systemic anticancer treatments. With regards to immunotherapy, there is uncertainty about its ef...

Full description

Bibliographic Details
Main Authors: Maristella Saponara, Laura Pala, Fabio Conforti, Marco Rubatto, Ivana De Risi, Francesco Spagnolo, Michele Guida, Paolo Bossi, Pietro Quaglino, Paola Queirolo
Format: Article
Language:English
Published: SAGE Publishing 2020-11-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920977002

Similar Items

Similar Items